GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mesoblast Ltd (ASX:MSB) » Definitions » Insider Ownership

Mesoblast (ASX:MSB) Insider Ownership : 0.00 % (As of Dec. 11, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Mesoblast Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Mesoblast's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Mesoblast's Institutional Ownership is 12.31%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Mesoblast's Float Percentage Of Total Shares Outstanding is 76.86%.


Mesoblast Insider Ownership Historical Data

The historical data trend for Mesoblast's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mesoblast Insider Ownership Chart

Mesoblast Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Insider Ownership
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Mesoblast Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Insider Ownership Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Mesoblast Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.


Mesoblast Business Description

Traded in Other Exchanges
Address
55 Collins Street, Level 38, Melbourne, VIC, AUS, 3000
Mesoblast Ltd is a biotechnology company. It uses its proprietary technology platform to develop and commercialize allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care and where inflammation plays a central role. The company's product candidates include; Ryoncil (remestemcel-L) for the treatment of steroid refractory acute graft versus host disease as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of cell technology platform for commercialization.

Mesoblast Headlines

From GuruFocus

Mesabi Trust Press Release

By Business Wire Business Wire 05-31-2023

Mesabi Trust Press Release

By Business Wire 07-12-2024

Top 5 4th Quarter Trades of MAD RIVER INVESTORS

By GuruFocus Research GuruFocus Editor 02-06-2023

Mesabi Trust Stock Appears To Be Significantly Overvalued

By GF Value GF Value 04-30-2021

Mesabi Trust Press Release

By Business Wire 01-12-2024

Mesabi Trust Press Release

By Business Wire 10-13-2023

Mesabi Trust Press Release

By Business Wire Business Wire 07-12-2021

Mesabi Trust Press Release

By Business Wire Business Wire 04-15-2022

Mesabi Trust Press Release

By Business Wire Business Wire 10-08-2021